Used in biomedical research to detect and quantify oligomeric forms of specific proteins in human biological samples such as serum, plasma, or cerebrospinal fluid. Commonly applied in neuroscience and Alzheimer’s disease studies to measure levels of toxic oligomers, particularly those derived from amyloid-beta or tau proteins, which are associated with disease progression. Enables researchers to assess biomarker levels in clinical samples, supporting diagnostic development and therapeutic monitoring. Widely used in preclinical studies to evaluate drug efficacy in modulating protein aggregation. Suitable for high-throughput screening in pharmaceutical research and validation of target engagement in clinical trials.